Model
Edge
Kinnate BioPharma Inc.
KNTE
Filing type
8-K
Filing date
Apr 2, 2024
Updated
Apr 3, 2024 ยท 3:28 AM
Copy reference
Filing
8-K
Notice of Exempt Offering of Securities
Exhibits
EX-3.1
EX-3.1
EX-3.2
EX-3.2